Tarnawski A
Division of Gastroenterology, University of California-Irvine, and Department of Veterans Affairs Medical Center, Long Beach, California 90288, USA.
Drug News Perspect. 2000 Apr;13(3):158-68. doi: 10.1358/dnp.2000.13.3.858438.
An ulcer in the gastrointestinal tract is a deep necrotic lesion penetrating the entire mucosal thickness and muscularis mucosae. Ulcer healing is an active process of filling the mucosal defect with proliferating and migrating epithelial and connective tissue cells. At the ulcer margin, epithelial cells proliferate and migrate onto the granulation tissue to cover (reepithelialize) the ulcer and also invade granulation tissue to reconstruct glandular structures within the ulcer scar. The reepithelialization and reconstruction of glandular structures is controlled by growth factors: trefoil peptides, EGF, HGF, bFGF and PDGF; and locally produced cytokines by regenerating cells in an orderly fashion and integrated manner to ensure the quality of mucosal restoration. These growth factors, most notably EGF, trigger cell proliferation via signal transduction pathways involving EGF-R, adapter proteins (Grb2, Shc and Sos), Ras, Raf1 and MAP (Erk1/Erk2) kinases, which, after translocation to nuclei, activate transcription factors and cell proliferation. Cell migration requires cytoskeletal rearrangements and is controlled by growth factors via Rho/Rac and signaling pathways involving PLC-gamma, PI-3 K and phosphorylation of focal adhesion proteins. Granulation tissue develops at the ulcer base. It consists of connective tissue cells: fibroblasts, macrophages and proliferating endothelial cells forming microvessels under the control of angiogenic growth factors: bFGF, VEGF and angiopoietins, which all promote angiogenesiscapillary vessel formation, essential for the restoration of microvascular network in the mucosa and thus crucial for oxygen and nutrient supply. The major mechanism of activation of angiogenic growth factors and their receptor expression appears to be hypoxia, which activates hypoxia-inducible factor, which binds to VEGF promoter.
胃肠道溃疡是一种穿透整个黏膜厚度和黏膜肌层的深部坏死性病变。溃疡愈合是一个用增殖和迁移的上皮及结缔组织细胞填充黏膜缺损的活跃过程。在溃疡边缘,上皮细胞增殖并迁移到肉芽组织上以覆盖(重新上皮化)溃疡,同时侵入肉芽组织以重建溃疡瘢痕内的腺体结构。腺体结构的重新上皮化和重建由生长因子控制:三叶肽、表皮生长因子(EGF)、肝细胞生长因子(HGF)、碱性成纤维细胞生长因子(bFGF)和血小板衍生生长因子(PDGF);以及由再生细胞以有序和整合的方式局部产生的细胞因子,以确保黏膜修复的质量。这些生长因子,最显著的是EGF,通过涉及EGF受体、衔接蛋白(Grb2、Shc和Sos)、Ras、Raf1和丝裂原活化蛋白(Erk1/Erk2)激酶的信号转导途径触发细胞增殖,这些激酶在转移到细胞核后激活转录因子和细胞增殖。细胞迁移需要细胞骨架重排,并由生长因子通过Rho/Rac以及涉及磷脂酶C-γ、磷脂酰肌醇-3激酶(PI-3 K)和粘着斑蛋白磷酸化的信号通路控制。肉芽组织在溃疡底部形成。它由结缔组织细胞组成:成纤维细胞、巨噬细胞和增殖的内皮细胞,在血管生成生长因子:bFGF、血管内皮生长因子(VEGF)和血管生成素的控制下形成微血管,这些因子均促进血管生成——毛细血管形成,这对于黏膜微血管网络的恢复至关重要,因此对于氧气和营养供应也至关重要。血管生成生长因子及其受体表达激活的主要机制似乎是缺氧,缺氧激活缺氧诱导因子,后者与VEGF启动子结合。